Serina Therapeutics (SER) Receivables (2017 - 2024)
Serina Therapeutics (SER) recorded Receivables of $65,000 in Q1 2024, up 983.3% from $6,000 a year earlier and up 14.0% from the prior quarter.
Powered by 
Analysis
Serina Therapeutics (SER) Receivables (2017 - 2024) Analysis & Trends
At the end of FY2023, Serina Therapeutics reported Receivables of $57,000.
- Annual Receivables has a five-year compound annual growth rate of -22.9% (FY2018 to FY2023).
- Across earlier years, Receivables came in at $4,000 in FY2022 (-84.0%), $25,000 in FY2021 (-92.3%), $326,000 in FY2020 (-10.2%) and $363,000 in FY2019 (+73.7%).
- Quarterly Receivables has ranged from $1,000 in Q3 2022 to $366,000 in Q1 2020 over the past five years.
- On a year-over-year basis, Receivables rose in two of the last five quarters, with growth averaging 152.5%.
- Peak year-over-year performance for Receivables in the last five years was growth of 983.3% in Q1 2024, against a decline of 95.8% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $57,000 (Q4 2023), $67,000 (Q3 2023) and $6,000 (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Serina Therapeutics | 32.93 Mn | -7.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 65,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Sep 30, 2023 | 67,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Dec 31, 2021 | 25,000.00 |
| Sep 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 11,000.00 |
| Mar 31, 2021 | 48,000.00 |
| Dec 31, 2020 | 326,000.00 |
| Sep 30, 2020 | 241,000.00 |
| Jun 30, 2020 | 235,000.00 |
| Mar 31, 2020 | 366,000.00 |
| Dec 31, 2019 | 363,000.00 |
| Sep 30, 2019 | 234,000.00 |
| Jun 30, 2019 | 286,000.00 |
| Mar 31, 2019 | 222,000.00 |
API Access
Serina Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=SER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "SER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=SER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();